Differential binding of nuclear proteins to the TP53 gene promoter in male breast tumour
European Journal of Cancer, ISSN: 0959-8049, Vol: 33, Issue: 9, Page: 1484-1487
1997
- 8Citations
- 2Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations8
- Citation Indexes8
- CrossRef1
- Captures2
- Readers2
Article Description
It is well established that TP53 regulates the expression of many genes, but the regulation of expression of TP53 itself is poorly understood. Recently, it has been shown that there is a tissue-specific binding of nuclear proteins in the TP53 gene promoter. The aim of this study was to determine the nuclear proteins that bind to the TP53 promoter elements (between −104 and −458) in male breast cancer. The results of our study, using the electrophoretic mobility shift assay (EMSA) and Southwestern analysis, have showed: (1) nuclear proteins or factors other than p53 bind to the TP53 promoter; (2) the levels of at least four nuclear proteins vary between normal and tumour breast tissue; and (3) two newly discovered nuclear proteins bind to the TP53 promoter in tumour tissue but are absent in normal tissue. This differential binding of nuclear proteins to the TP53 gene promoter might play a critical role in TP53 transcription and cancer progression in male breast tumours.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0959804997001640; http://dx.doi.org/10.1016/s0959-8049(97)00164-0; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0030773486&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/9337693; https://linkinghub.elsevier.com/retrieve/pii/S0959804997001640; http://dx.doi.org/10.1016/s0959-8049%2897%2900164-0; https://dx.doi.org/10.1016/s0959-8049%2897%2900164-0
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know